Cargando…

A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma

PURPOSE: Gap junction protein (Connexin) family is the basic unit of cellular connection, whose multiple members were recently demonstrated to be associated with tumor progression. However, the expression pattern and prognostic value of connexin in lung adenocarcinoma (LUAD) have not yet been elucid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Junqing, Yin, Jun, Ding, Guowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581606/ https://www.ncbi.nlm.nih.gov/pubmed/36276289 http://dx.doi.org/10.1155/2022/9261339

Ejemplares similares

Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2022)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
por: Yang, Weichang, et al.
Publicado: (2023)

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
por: Liu, Zhonghui, et al.
Publicado: (2021)

Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients
por: Liu, Junhui, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing
por: Yang, Jia, et al.
Publicado: (2023)

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2022)

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma
por: Zhang, Liangming, et al.
Publicado: (2022)

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
por: Yang, Jian, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
por: Wang, Xinyi, et al.
Publicado: (2023)

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma
por: Nai, Aitao, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Cross-talk of pyroptosis and tumor immune landscape in lung adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2021)

A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape
por: Dong, Lingjun, et al.
Publicado: (2023)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
por: Peng, Xinyi, et al.
Publicado: (2023)

Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma
por: Ren, Caixia, et al.
Publicado: (2022)

Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma
por: Yin, Xiang-Qian, et al.
Publicado: (2022)

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma
por: Wang, Yanyun, et al.
Publicado: (2020)

Characterization of the alternative splicing landscape in lung adenocarcinoma reveals novel prognosis signature associated with B cells
por: Shao, Ming-Ming, et al.
Publicado: (2023)

Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
por: Guo, Zehuai, et al.
Publicado: (2023)

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
por: Brcic, Luka, et al.
Publicado: (2018)

Higher Incidence of Lung Adenocarcinomas Induced by DMBA in Connexin 43 Heterozygous Knockout Mice
por: Duro de Oliveira, Krishna, et al.
Publicado: (2013)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

The global landscape of intron retentions in lung adenocarcinoma
por: Zhang, Qu, et al.
Publicado: (2014)

Identification of m7G-Related miRNA Signatures Associated with Prognosis, Oxidative Stress, and Immune Landscape in Lung Adenocarcinoma
por: Jiang, Sujing, et al.
Publicado: (2023)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
por: Fan, Zhengyang, et al.
Publicado: (2023)

The relationship between tumor infiltrating immune cells and the prognosis of patients with lung adenocarcinoma
por: Tong, Zhuang, et al.
Publicado: (2023)

Prognostic value and immune landscapes of immunogenic cell death-associated lncRNAs in lung adenocarcinoma
por: Shu, Kexin, et al.
Publicado: (2023)

Connexins in Lung Cancer and Brain Metastasis
por: Luo, Kai-Jun, et al.
Publicado: (2020)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
por: Yang, Yefan, et al.
Publicado: (2022)

Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma
por: Wang, Ye, et al.
Publicado: (2022)

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma
por: Zou, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gnsnspb2ln1aqvtqvf90mlni3h